SogoTrade Research Center








For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
Bristol-Myers Squibb Company
(NYSE: BMY) Add to Portfolio
$65.17
-0.54 (-0.82%)
as of Feb 20, 2020

Last 65.17
Change -0.54 (-0.82%)
Open 65.63
Prev. Close 65.71
Today's Range
64.89 65.98
52wk Range
42.48 68.34
Volume 11,360,500
Avg Volume 12,978,425
Sector SIC-2834 Pharmaceutical Preparations

Recent Headlines
The global Antiviral Drugs Market is set to gain impetus from the improvements in research collaborations of industry giants to develop state-of-the-art therapeutics. Besides, the increasing prevalence of viral diseases would impa (full story)
BMY: 65.17 (-0.54), GILD: 67.00 (-0.35), GSK: 42.76 (-0.13), MRK: 82.49 (+0.49), NVS: 96.29 (-0.93)
Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the fourth quarter and full year ended December 31, 2019. (full story)
BMY: 65.17 (-0.54), CGEN: 10.51 (+0.73)
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, today announced its plan to initiate a Phase 1/2 study evaluating a triple combination of Compugen's COM701, an (full story)
BMY: 65.17 (-0.54), CGEN: 10.51 (+0.73)
The "Immunosuppressant Drugs Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. (full story)
ALPMF: 17.1800 (unch), BMY: 65.17 (-0.54)
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Michael Quigley, PhD has joined the company as Senior Vice President, Research Biology, bringing to the role deep experience in oncology and immuno-oncology biology. (full story)
BMY: 65.17 (-0.54), GILD: 67.00 (-0.35)
 
Performance Comparison
Name Today 3-Month 1-Year
BMY -0.82% +8.71% +27.04%
Growth Rates
YTD +1.53%
1-Year +27.83%
3-Year +15.47%
5-Year +6.98%
10-Year +165.89%
© 2020 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.